The Evaluation of Benign Prostate Hyperplasia and Chronic Prostatitis Symptoms with Obstructive Sleep Apnea Syndrome Patients

Abstract

Obstructive Sleep Apnea Syndrome (OSAS) is a chronic disorder that increases in prevalence with increasing age. Oxidative stress (OS) and inflammation resulting from OSAS are responsible for the etiopathogenesis of many diseases. OS and inflammation have been found to play a role in the etiopathogenesis of benign prostate hyperplasia (BPH) and chronic prostatitis (CP). The present study aims to compare the prevalence of BPH and CP between patients diagnosed with OSAS and non-OSAS volunteers. Included in the study were 102 patients with OSAS and 110 non-OSAS volunteers, all of whom were assessed with the Berlin Questionnaire, the Epworth Sleepiness Scale, the International Prostate Symptom Score (IPSS) and the Chronic Prostatitis Symptom Index (CPSI). No significant difference was found in the age (p=0.267) and body mass index (BMI) (p=0.995) values of the OSAS patients and non-OSAS volunteers. Berlin Questionnaire (p<0.001) and Epworth Sleepiness Scale (p<0.001) positivity was more common among the OSAS patients than in the control group. The IPSS (p<0.001), CPSI pain score (p<0.001) and CPSI urination symptoms (p=0.002) values were higher in the OSAS patients than in the controls. OSAS patients had more BPH and CP symptoms than the controls. The effective treatment of OSAS is important for the prevention of such chronic diseases as BPH and CP that may develop at later stages of life and that can impair the quality of life of the patient.